In clinical exome and genome sequencing, there is a potential for the recognition and
reporting of incidental or secondary findings unrelated to the indication for ordering the …

Loss of the de novo DNA methyltransferases Dnmt3a and Dnmt3b in embryonic stem cells
obstructs differentiation; however, the role of these enzymes in somatic stem cells is largely …

… Berg, MD, Ph.D., … and Michael S. Watson, Ph.D. … The patient’s family pursues genetic
testing that shows a “likely pathogenic” variant for the condition on the basis of a study in an …

The past decade has seen a remarkable explosion in our knowledge of the size and diversity
of the myosin superfamily. Since these actin-based motors are candidates to provide the …

Next-generation sequencing technologies have been and continue to be deployed in clinical
laboratories, enabling rapid transformations in genomic medicine. These technologies …

Chromosome region 1q21.1 contains extensive and complex low-copy repeats, and copy
number variants (CNVs) in this region have recently been reported in association with …

… þ (s) using an e neighborhood around s; that is, all prediction scores s ∈ ½s À e, s þ e are
considered pathogenic and used to compute lr þ (s) and the local positive predictive value. …

Evaluating the pathogenicity of a variant is challenging given the plethora of types of genetic
evidence that laboratories consider. Deciding how to weigh each type of evidence is difficult…

Technological advances often outpace our ability to effec-tively use them, a situation that
certainly could pertain to modern genomics. Breathtaking advances in genetic sequencing …

In 1995, the American Society of Human Genetics (ASHG) and American College of Medical
Genetics and Genomics (ACMG) jointly published a statement on genetic testing in children …